CalCEF Clean Energy Angel Fund holds initial close toward $20M
The CalCEF Clean Energy Angel Fund is a network of limited partners that plans on investing in early-stage clean tech, doling out a planned $20 million fund in increments of $500,000 to $1 million.
The fund has held its first close, and plans investments in some less capital-intensive technologies like solar power micro-inverters and lighting systems.
It’s likely to steer clear of deals involving biofuels or energy generation, according to Susan Preston, the fund’s general partner…. Continue Reading
Life-science briefing: Wednesday, April 9, 2008
TODAY’S HEADLINES:
Stemline Therapeutics, cancer stem-cell startup, gets $13M (release)
Eye-disease biotech Potentia Pharma raises $12M (release)
Sample-prep toolmaker Arcxis aims for $8M to $10M (VentureWire)
Synvascular names Drew Hoffman as CEO (VentureWire)
ArtusLabs gets $2.6M for life-science software and services (release)
Cancer-drug maker Inotek loses CEO, Genentech partnership (release)
GTESS, health-plan IT startup, names James Bradley CEO (release)
Antibiotic developer Tetraphase Pharma names Guy MacDonald CEO (release)
Stemline Therapeutics, cancer stem-cell startup, gets $13M – New York-based Stemline Therapeutics, a biotech focused on new… Continue Reading